Usefulness of fragile X checklist and CGG distribution in specialized institutions in Kinshasa, DR Congo.

Behavioral manifestation Checklist Democratic Republic of Congo Dysmorphism Fragile X syndrome

Journal

Journal of community genetics
ISSN: 1868-310X
Titre abrégé: J Community Genet
Pays: Germany
ID NLM: 101551501

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 14 03 2018
accepted: 20 06 2018
pubmed: 6 7 2018
medline: 6 7 2018
entrez: 6 7 2018
Statut: ppublish

Résumé

Screening for fragile X syndrome (FXS) is essential in children with developmental delay or intellectual disability (ID). In addition, using clinical screening checklists remains of high interest in resource-limited settings. We aimed to gain insight into the prevalence of FXS and the distribution of CGG alleles and to evaluate the usefulness of three checklists in specialized institutions in Kinshasa, DR Congo. We recruited 80 males and 25 females from six specialized institutions in Kinshasa and administered a questionnaire comprising items from the following FXS checklists: Hagerman, Maes, and Guruju. FMR1 CGG repeats were assessed for every patient. About 37% of patients were referable for FX testing based on Hagerman's checklist, 35% for Maes', and 43.80% for Guruju's, but none of them was molecularly confirmed to have FXS. Thus, specificities were 62.86, 64.76, and 56.5%, respectively, for Hagerman, Maes, and Guruju, respectively. The mean CGG allele size was 28.55 ± 2.83 (ranges, 17-48). The 29 CGG was the most frequent allele (24.61%). Thus, existing checklists should not be automatically applied to Congolese patients without adjustments. The distribution of CGG repeats and the number of CGG alleles are similar to other African studies.

Identifiants

pubmed: 29974402
doi: 10.1007/s12687-018-0374-4
pii: 10.1007/s12687-018-0374-4
pmc: PMC6325043
doi:

Types de publication

Journal Article

Langues

eng

Pagination

153-159

Références

Am J Med Genet. 1999 May 28;84(3):202-3
pubmed: 10331591
Diagn Mol Pathol. 1999 Sep;8(3):152-6
pubmed: 10565687
Am J Med Genet. 2000 Jun 5;92(4):229-36
pubmed: 10842286
J Med Genet. 1999 Jun;36(6):467-70
pubmed: 10874635
Ment Retard. 2000 Jun;38(3):207-15
pubmed: 10900928
Hum Mol Genet. 2000 Jul 22;9(12):1759-69
pubmed: 10915764
Genet Med. 2001 May-Jun;3(3):200-5
pubmed: 11388762
Genet Med. 2001 Sep-Oct;3(5):359-71
pubmed: 11545690
Am J Med Genet. 2002 Jul 1;110(3):226-33
pubmed: 12116230
Am J Med Genet A. 2005 Apr 30;134(3):242-6
pubmed: 15754359
Eur J Med Genet. 2006 Jan-Feb;49(1):1-8
pubmed: 16473304
J Dev Behav Pediatr. 2006 Feb;27(1):63-74
pubmed: 16511373
Am J Med Genet A. 2006 Nov 1;140(21):2275-88
pubmed: 17022076
Nature. 2007 Jun 21;447(7147):932-40
pubmed: 17581576
Harefuah. 2007 Jun;146(6):469-74, 499
pubmed: 17760403
J Korean Med Sci. 2008 Jun;23(3):470-6
pubmed: 18583885
Clin Genet. 1991 May;39(5):347-54
pubmed: 1860251
Biochim Biophys Acta. 2009 Jun;1790(6):467-77
pubmed: 19233246
J Egypt Public Health Assoc. 2008;83(3-4):273-83
pubmed: 19302779
J Clin Neurosci. 2009 Oct;16(10):1305-10
pubmed: 19560928
J Med Genet. 2009 Sep;46(9):577-84
pubmed: 19724010
Am J Med Genet. 1991 Feb-Mar;38(2-3):256-9
pubmed: 2018069
Am J Med Genet. 1991 Feb-Mar;38(2-3):283-7
pubmed: 2018072
Ann Hum Genet. 2010 Jul;74(4):316-25
pubmed: 20597902
Genet Med. 2013 Jul;15(7):575-86
pubmed: 23765048
S Afr Med J. 2013 Oct 11;103(12 Suppl 1):994-8
pubmed: 24300646
Pediatrics. 2014 Sep;134(3):e903-18
pubmed: 25157020
Intractable Rare Dis Res. 2014 Nov;3(4):134-46
pubmed: 25606363
Clin Dysmorphol. 2018 Apr;27(2):66-69
pubmed: 29319541
Am J Med Genet. 1988 May-Jun;30(1-2):641-54
pubmed: 3177476
Nucleic Acids Res. 1988 Feb 11;16(3):1215
pubmed: 3344216
Hum Mol Genet. 1995 Dec;4(12):2199-208
pubmed: 8634688
Am J Hum Genet. 1996 Mar;58(3):513-22
pubmed: 8644711
Am J Med Genet. 1996 Jul 12;64(1):196-7
pubmed: 8826475
Am J Med Genet. 1996 Jul 12;64(1):216-9
pubmed: 8826479
Am J Med Genet. 1996 Jul 12;64(1):220-5
pubmed: 8826480
J Med Genet. 1998 Oct;35(10):878
pubmed: 9783718

Auteurs

Aimé Lumaka (A)

Centre for Human Genetics, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4500, Liège, Belgium.
Department of Pediatrics, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.

Toni Kasole Lubala (TK)

Division of Dysmorphology and Birth Defects, Department of Pediatrics, University of Lubumbashi, Lubumbashi, Congo.

Valérie Race (V)

Centre for Human Genetics, University Hospitals, University of Leuven, Herestraat 49, Bus 602, 3000, Leuven, Belgium.

Hilde Peeters (H)

Centre for Human Genetics, University Hospitals, University of Leuven, Herestraat 49, Bus 602, 3000, Leuven, Belgium.

Prosper Lukusa (P)

Centre for Human Genetics, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Department of Pediatrics, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Centre for Human Genetics, University Hospitals, University of Leuven, Herestraat 49, Bus 602, 3000, Leuven, Belgium.

Koenraad Devriendt (K)

Centre for Human Genetics, University Hospitals, University of Leuven, Herestraat 49, Bus 602, 3000, Leuven, Belgium. koenraad.devriendt@uzleuven.be.

Classifications MeSH